Market Exclusive

Analyst Activity – Canaccord Genuity Reiterates Buy on Edwards Lifesciences (NYSE:EW)

Analyst Ratings For Edwards Lifesciences (NYSE:EW)

Today, Canaccord Genuity reiterated its Buy rating on Edwards Lifesciences (NYSE:EW) with a price target of $174.00.

Some recent analyst ratings include

Recent Insider Trading Activity For Edwards Lifesciences (NYSE:EW)
Edwards Lifesciences (NYSE:EW) has insider ownership of 2.13% and institutional ownership of 81.78%.

Recent Trading Activity for Edwards Lifesciences (NYSE:EW)
Shares of Edwards Lifesciences closed the previous trading session at 136.07 up +9.09 7.16% with shares trading hands.

Exit mobile version